OQS
HOLX

Occudo Quantitative Strategies’s Hologic HOLX Stock Holding History

Occudo Quantitative Strategies’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-45,083
Closed -$2.76M – 751
2025
Q1 		$2.76M Buy
+45,083
New +$2.99M 0.37% 67
2024
Q1 		– Sell
-10,633
Closed -$760K – 866
2023
Q4 		$760K Buy
10,633
+1,174
+12% +$81.7K 0.1% 273
2023
Q3 		$656K Buy
+9,459
New +$715K 0.08% 408
2022
Q2 		– Sell
-32,154
Closed -$2.47M – 1237
2022
Q1 		$2.47M Buy
32,154
+23,645
+278% +$1.7M 0.21% 118
2021
Q4 		$651K Buy
+8,509
New +$625K 0.06% 519
2021
Q3 		– Sell
-26,067
Closed -$1.74M – 1067
2021
Q2 		$1.74M Buy
26,067
+22,817
+702% +$1.53M 0.27% 86
2021
Q1 		$242K Buy
3,250
+20
+0.6% +$1.52K 0.05% 561
2020
Q4 		$235K Buy
+3,230
New +$228K 0.07% 497

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Occudo Quantitative Strategies's HOLX Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of Hologic (HOLX) in Q2 2025, closing a stake of 45,083 shares — an estimated $2.76M sold.

Occudo Quantitative Strategies first reported a position in HOLX in Q4 2020 and held it in 8 quarters. The position peaked at $2.76M in Q1 2025. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 45,083 Hologic shares in Q2 2025, an estimated $2.76M.
  • Occudo Quantitative Strategies first reported a position in Hologic in Q4 2020 and held it in 8 quarters.
  • Occudo Quantitative Strategies's Hologic position peaked at $2.76M in Q1 2025.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.